Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,477 total articles
Axon is delivering impressive bookings and software momentum, but free cash flow remains tiny versus a $40 billion market cap. This trade idea takes a cautious long stance: participate in the recovery while protecting capital until cash conversion accelerates.
Gray Media (GTN) trades like a distressed broadcaster on a modest market cap but with operating scale across 117 markets, a new Political 360 offering, restored carriage deals and a manageable free cash flow profile. The balance sheet is levered and the company has been active on the financing front, but if political ad spending materializes this f…
Nano Labs trades at a sub-$50M market cap with a P/E of 1.90 and P/B of 0.39, supported by product launches, an April 2026 MOU to evaluate North America AI data centers, and recent insider buying. Heavy short interest raises risk but also creates a path to rapid upside if execution and visibility improve. This is a high-risk long trade for patient …
Joby has moved from lab to real-world testing: heavy flight hours, FAA progress, and partner commitments justify a speculative long. Price has been punished, leaving a tradable risk/reward where certification and early commercial ramps can re-rate the stock. This plan outlines a clear entry, stop and target with catalysts and balanced risks.
Advanced Micro Devices has the product stack, partnerships, and cash flow to catch a fresh bid as AI cloud and enterprise demand ramps. A disciplined entry at $525 with a $495 stop and a $600 target over the next 45 trading days balances upside from continued Helios and EPYC/Instinct wins against a still-rich valuation.
Take-Two is priced like a turnaround; Grand Theft Auto VI landing on 11/19/2026 is the obvious binary catalyst to lift bookings, margins, and multiple. The company already shows positive free cash flow and a high recurring revenue mix. This trade targets a re-rating into year-end while keeping risk controls tight.
SoFi has executed on member growth and deposit accumulation while returning to profitability metrics. The stock trades at a market cap of roughly $21.1B and looks cheap relative to its growth trajectory if management's 30% revenue CAGR target holds. This trade idea outlines an entry at the current price, a conservative stop under the 52-week low, a…
ServiceNow looks like a survival story, not a casualty, despite broad pressure on SaaS multiples. Strong recurring revenue at scale, $4B quarterly revenue momentum, $4.63B in free cash flow and low leverage create a buffer while sentiment resets. This is a tactical long (swing) with a $99 entry, $88 stop and $130 target over 45 trading days.
AppFolio's SaaS moat in property management is being amplified by new AI-driven workflow modules and strong unit economics. At roughly $165, the market offers an attractive risk/reward for a long trade: solid revenue growth, high free cash flow conversion, and an addressable PropTech market tailwind. We outline a clear entry, stop and target with a…
Charter (CHTR) trades at single-digit earnings multiples and dirt-cheap FCF valuation against a $4.3B free cash flow run-rate. That bargain is counterbalanced by a heavy debt load, weak liquidity ratios, and secular pressure on video. I outline a mid-term (45 trading days) swing trade that buys a meaningful margin for error while respecting downsid…
Reddit is trading well below its 52-week high after a recent pullback. With quarterly revenue accelerating (recent quarter +69%), net cash on the balance sheet, and growing relevance to AI discovery, the risk/reward looks attractive from current levels. This trade idea lays out a specific entry, stop and long-term target with time-horizon milestone…
We initiate a trade idea on Medtronic (MDT) as a mid-term buy centered on momentum in the MiniMed diabetes platform. Attractive yield, healthy free cash flow ($5.43B), and valuation metrics (PE ~22, EV/EBITDA 13.5) underpin the setup. Entry $83.21, stop $76.00, target $95.00 over 45 trading days.
Hesai (HSAI) is a cash-generating LiDAR vendor with scale: quarterly shipments of 631,095 units and Q4 2025 revenue of RMB1,000.5M (US$143.1M). The stock is trading near its 52-week low after a sharp re-rating from 2025 highs. We like a disciplined long position that leans on recurring ADAS orders and a ramp into robotics/robotaxi customers to wide…
Advanced Energy Industries (AEIS) supplies precision power conversion hardware that is seeing outsized demand from AI data centers and advanced semiconductor tool customers. Recent beats and management commentary point to sustained data center revenue growth and margin expansion. The stock recently pulled back into the low $300s and offers a favora…
Nebius has the ingredients to become the de facto infrastructure and services hub for open-source, safety-focused generative models. Backed by massive contracted revenue, a recent Nvidia equity stake and 684% YoY quarterly growth, the stock's recent pullback creates a tactical buying opportunity. This is a high-conviction, high-risk trade: enter at…
<p>Taiwan Semiconductor (TSM) is the best defensive way to capture the AI infrastructure boom. The company is reporting strong top-line momentum - Q2 revenue growth of 34% year-over-year and a June spike of 68% - while expanding U.S. capacity with an extra $100 billion commitment and raising capex guidance to $60-64 billion. That scale and customer…
Monolithic Power Systems (MPWR) sits squarely in the AI data-center value chain, delivering high-efficiency, high-power-density power ICs that are critical as GPUs and accelerators push thermal and power bills higher. Recent results show Enterprise Data revenue nearly doubled and management gave aggressive guidance; fundamentals (free cash flow $62…
Sezzle has moved from a pure BNPL player to a broader fintech play with product expansion, strong subscriber growth and healthy cash generation. At roughly $5.17B market cap and trading near $153.63, the stock looks like a high-growth compounder that can re-rate if execution on new products and continued revenue acceleration hold. This trade target…
Oscar Health looks to be transitioning from growth-at-all-costs to profitable scale. Membership gains and margin leverage have pushed free cash flow positive and management now guides to operating income in 2026. At roughly $8.5B market cap and $4.34B enterprise value, the stock offers a tactical long with defined entry, stop and target levels cali…
Alphabet reported powerful Q2 growth in Search and Google Cloud and followed with heavy capex guidance. The market punished the stock on the capex news, but fundamentals point to continued AI-led revenue and margin expansion. This trade idea lays out an actionable long trade with entry, stop and target for a long-term (180 trading days) horizon and…
Astec Industries is delivering above-peer growth in its Materials segment and guiding to materially higher adjusted EBITDA for 2026. The market has not fully priced that improvement: while the trailing P/E sits elevated, the company's $1.61B enterprise value implies an attractive ~9x EV/EBITDA on management's 2026 midpoint. We lay out an actionable…
Nu Holdings is the dominant digital challenger bank in Latin America, growing customers rapidly while maintaining strong returns on equity and improving operating efficiency. The stock trades around $14 with a market cap near $71B and a trailing P/E near 21x — an attractive entry for investors who believe growth and margin expansion will continue. …
Alphabet is delivering outsized AI-driven growth in Search and Cloud while guiding materially higher capex. The market punished shares on headline spending, but fundamentals - 17% Search growth, 82% Google Cloud growth, $64.4B free cash flow and a $514B backlog - argue for buying the dip. This trade idea outlines a long-term (180 trading days) plan…
Exelixis is a liquid, profitable oncology company trading near $55.40 with a $13.9B market cap. Recent pipeline progress for zanzalintinib and durable cash flow from Cabometyx create a compelling mid-term long trade: entry at $55.50, stop at $50.00, target $64.00 over ~45 trading days. The balance sheet and free cash flow ($912M) underpin execution…
Alibaba is trading well below its 52-week high despite improving technical momentum and a clear pathway to monetize large-language-model assets through Alibaba Cloud and product integrations. This trade idea takes a constructive view on Qwen-driven AI adoption while defining risk with a tight stop and a realistic mid-term target.
